Step right up to witness the greatest “big top” celebration the world has ever seen. The 14th Annual Avon Heritage Duck Tape® Festival sets up Father’s Day weekend – Friday, June 16 through Sunday, June 18, 2017 – with a theme to entertain men, women and children of all ages. That’s right, folks, the Duck Tape® “circus” is coming to town!
Available in hundreds of colors, designs and licenses, America’s favorite fix-all is ready for the spotlight. Head out to Veterans Memorial Park in Avon, Ohio to be amazed, amused and astonished by a most-incredible Duck Tape® “Circus Spectacular”: from a circus-themed parade featuring floats made with Duck Tape®, larger-than-life Duck Tape® sculptures to lots of fun under the arts and crafts tent and a community fashion show. Families can also enjoy delicious fair food favorites (cotton candy, anyone?), rides and attractions, including family-friendly games, live entertainment and more. Plus, the first 500 spectators each day will receive a free roll of Duck Tape®.
To view the multimedia release go to:
https://www.multivu.com/players/English/8109351-duck-tape-avon-heritage-festival-circus-spectacular/
GW Pharmaceuticals plc (Nasdaq: GWPH, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, along with its U.S. subsidiary Greenwich Biosciences, announced today that The New England Journal of Medicine has published results from a Phase 3 study of Epidiolex® (cannabidiol) in children with Dravet syndrome.1 Epidiolex, GW’s lead product candidate and the potential first in a new category of anti-epileptic drugs, is a liquid formulation of purified, plant-derived cannabidiol (CBD), a non-psychoactive cannabinoid, which is being studied for the treatment of a number of rare, severe pediatric-onset epilepsy disorders. In the study, Epidiolex significantly reduced monthly convulsive seizure frequency compared to placebo in highly treatment-resistant children when added to existing treatment. Treatment with Epidiolex was generally well tolerated, with a safety profile consistent with prior open label experience.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8109951-gw-pharmaceuticals-study-epidiolex/
Changes in the treatment of pediatric cancer over recent decades have translated to a reduced risk of serious, long-term late health effects of cancer therapy. This is according to the latest analysis from the Childhood Cancer Survivor Study (CCSS), a National Cancer Institute-funded resource for late-effects research, led by investigators at St. Jude Children’s Research Hospital.
“This is the first comprehensive study to demonstrate how changes in treatments over time have impacted the occurrence of late effects experienced by childhood cancer survivors,” said Todd Gibson, Ph.D., assistant member of the Department of Epidemiology and Cancer Control at St. Jude. “We found the 15-year cumulative incidence of people reporting at least one severe health condition decreased from 12.7 percent among childhood cancer survivors diagnosed in the 1970s to 10.1 percent for those diagnosed in the 1980s to 8.8 percent in the 1990s–a statistically significant decline.”
To view the multimedia release go to:
https://www.multivu.com/players/English/7924756-st-jude-childhood-cancer-survivorship-asco-2017/
Summit Homes, a Berkshire Hathaway subsidiary through Clayton Properties Group, presented St. Jude Children’s Research Hospital representatives a check for $718,000 following the sale of the builder’s 2017 St. Jude Dream Home Showplace.
Summit Homes, the largest new home builder in Kansas City, built the 2017 St. Jude Dream Home Showplace as an extension of the St. Jude Dream Home® Giveaway Program, to support children battling cancer and other catastrophic diseases. The builder pledged 100% of proceeds from the sale of the home to as a donation for the research hospital.
To view the multimedia release go to:
https://www.multivu.com/players/English/8011654-clayton-summit-homes-st-jude-dream-home-2017/
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of the Fluzone® (Influenza Vaccine) portfolio for the 2017-2018 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA). Sanofi Pasteur has begun distributing initial shipments, representing the first of nearly 70 million total doses of seasonal influenza vaccine manufactured by the company for this upcoming influenza season. Widespread shipment of Fluzone Quadrivalent, Fluzone High-Dose and Fluzone Intradermal Quadrivalent vaccine to health care provider offices, pharmacies and other immunizers will begin in early August to support fall immunization campaigns.
“As we enter the Swiftwater site’s 120th year, it reminds us of our innovation and growth as we came to understand the science of influenza and its impact on human health,” said David P. Greenberg, M.D., Associate Vice President and Regional Medical Head North America, Sanofi Pasteur. “Influenza can be especially severe for the most vulnerable populations, including the elderly, young children and those with compromised immune systems; however, it can also have a serious health impact on otherwise healthy individuals. Sanofi Pasteur is and always has been deeply committed to improving public health by continuously striving to develop new vaccines and on improving existing ones.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8081151-sanofi-pasteur-influenza-vaccine-first-shipment-2017/
Today, HHS’ Administration for Children and Families (ACF), along with the National Responsible Fatherhood Clearinghouse, has launched a new series of public service advertisements (PSAs) recognizing the critical role fathers play in the lives of their children.
The public service campaign created by the non-profit Ad Council coincides with Tell a Joke Day and centers on the popularity and growing trend of telling “Dad” jokes. Through sharing dad jokes, the PSAs aim to communicate to fathers that the smallest moments spent with their children can make the biggest difference in their children’s lives. The ads direct fathers to Fatherhood.gov where users will find helpful tips, tools, information and jokes to help them get more involved with their kids.
To view the multimedia release go to:
https://www.multivu.com/players/English/8156551-ad-council-fatherhood-dad-jokes/
Cancer takes more children’s lives than any other disease in the U.S., and nearly 25,000 kids will be diagnosed during the month of September alone. As the largest private funder of childhood cancer research grants, the St. Baldrick’s Foundation is on a mission to take childhood back from cancer by raising critical dollars for lifesaving research and spreading awareness about the harsh realities of childhood cancer.
This September, in recognition of Childhood Cancer Awareness Month, St. Baldrick’s will show how the research it funds is accelerating the development of new therapies and cures for kids with cancer everywhere. The Foundation will also share stories of kids affected by cancer – kids like David and Hazel who were both diagnosed with neuroblastoma, but faced two different outcomes.
To view the multimedia release go to:
https://www.multivu.com/players/English/7916553-st-baldricks-childhood-cancer-awareness-month/
In an effort to improve outcomes for patients with some of the deadliest childhood cancers, St. Jude Children’s Research Hospital scientists have created the world’s largest collection of pediatric solid tumor samples, drug-sensitivity data and related information and have made the resource available at no charge to the global scientific community.
St. Jude and the Howard Hughes Medical Institute collaborated to create the resource, known as the Childhood Solid Tumor Network. The work is reported today as an advance online publication in the scientific journal Nature.
“Survival rates for children with recurrent solid tumors have not improved significantly in more than 20 years and remain below 30 percent,” said corresponding author Michael Dyer, Ph.D., chair of the St. Jude Department of Developmental Neurobiology and a Howard Hughes Medical Institute investigator. “This research will change that by promoting scientific collaboration to leverage the efforts of researchers worldwide to advance understanding and ultimately treatment of pediatric solid tumors.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8121952-st-jude-childrens-childhood-solid-tumor-network/
Blood cancers are the third leading cause of cancer deaths in the U.S. However, many Americans are unaware of the impact of these cancers, including leukemia, lymphoma and myeloma, which affect the bone marrow, the blood cells, the lymph nodes and other parts of the lymphatic system.
A new survey commissioned by The Leukemia & Lymphoma Society (LLS) reveals more than four in five adults (82%) are surprised that blood cancers are the third leading cancer killer of Americans. Further, nearly four in five adults (78%) are surprised that acute lymphocytic leukemia (ALL) is the most common cancer in children and young adults under age 20.
To view the multimedia release go to:
https://www.multivu.com/players/English/8128551-lls-blood-cancer-awareness-month/
To motivate parents and their children to spend more time in nature together, the U.S. Forest Service and the Ad Council today launched a new public service advertisement (PSA) campaign urging families to experience the many wonders of nature close to home together.
The PSAs, created in partnership with The Foundry, Time Inc.’s state-of-the-art creative lab and content studio, focus on family time in nearby forested environments, reminding parents that having a nature experience with their children is not only easy and local, but also fun and full of learning opportunities and benefits. This is the first time that the Ad Council has worked with the creative division of a media company that has iconic roots in publishing on a large-scale production on behalf of one of its PSA campaigns. A range of Time Inc. properties are also donating print and digital advertising space in support of this campaign.
To view the multimedia release go to:
https://www.multivu.com/players/English/8171051-new-ad-council-u-s-forest-services-discover-the-forest-psa/
This October, Red Gold is making it easy for people to give back when sharing their family meal. For any Red Gold canned tomato product purchased throughout the month, Red Gold will donate one meal* to help families facing hunger, with a goal of donating 2 million meals to Feeding America and its network of food banks. Whether it’s labeled Red Gold, Redpack, Tuttorosso or Huy Fong, consumers can simply buy a can, and help feed a family.
The philanthropic effort comes at a time when millions of American families struggle to put food on the table. According to recent data from the U.S. Department of Agriculture (USDA), 1 in 8 Americans face hunger, including 13 million children. However, most families don’t recognize the extent of hunger in America; a Red Gold survey found that nearly 7 in 10 households were either unsure of the number of Americans struggling with hunger, or they severely underestimated the problem.
To view the multimedia release go to:
https://www.multivu.com/players/English/8111351-red-gold-feeding-america-crush-hunger-october-2017/
Academy of Country Music's Male Vocalist of the Year Thomas Rhett will perform LIVE at AT&T Stadium during the nationally televised halftime of the Dallas Cowboys game against the Los Angeles Chargers on Thanksgiving Day, kicking off The Salvation Army's annual Red Kettle Campaign. Donations to the iconic campaign help provide shelter and meals for the homeless and hungry, and Christmas toys for millions of children, in addition to numerous other social service programs The Salvation Army provides year-round.
To view the multimedia release go to:
https://www.multivu.com/players/English/8179631-salvation-army-red-kettle-fight-for-good/
